BiomimX, spin-off of Politecnico di Milano’s Dipartimento di Elettronica, Informazione e Bioingegneria, won first place in the 2021 Cross the Bridge competition called by Camera di Commercio Milano Monza Brianza Lodi, earning a 50.000 € prize to implement its project activities.

Established in 2017, BiomimX develops advanced organs-on-chip platforms as in vitro pre-clinical models to improve the drug development process. The company proprietary technology uBeat supports 3D cell co-culture and integrates a controlled and tunable mechanical stimulation, leading to the generation of mature and functional miniaturized organs adequate to test compounds toxicity/functionality in a high-throughput fashion. The company organs’ portfolio comprises, among others, uHeart, a human heart-on-chip (winner of StartCup Lombardia 2016) and uKnee, the first miniaturized model of human osteoarthritic joint.